MIEBO (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease. IMPORTANT SAFETY INFORMATION. Patients should remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting. It is important for patients to use MIEBO exactly as prescribed.
Official HCP site. Review important product information including efficacy and safety. Please see full Prescribing Information for MIEBO (perfluorohexyloctane ophthalmic solution).
be removed before use and for at least 30 minutes after administration of MIEBO Instruct patients to instill one drop of MIEBO into each eye four times daily Please see additional Important Safety Information throughout. Click here for full Prescribing Information for MIEBO. Indicated for the treatment of the signs and symptoms of DED1
MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBO (perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2024 -INDICATIONS AND USAGE- MIEBO (perfluorohexyloctane ophthalmic solution) is a semifluorinated
MIEBO (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease. It is the first and only prescription eye drop that directly targets tear evaporation. Prescribing Information. Consumer Site. Professional Site. More Information. Miebo Savings and Support. Patient Assistance Program.
(Miebo) is a topical ophthalmic solution most recently 20. The Food and Drug Administration. Highlights of Prescribing Information
Official HCP site. Review important product information including efficacy and safety. Please see full Prescribing Information for MIEBO (perfluorohexyloctane ophthalmic solution).
Important safety information for Xiidra and Miebo Patients should remove contact lenses before using Miebo and wait for at least 30 minutes
Official HCP site. Review important product information including efficacy and safety. Please see full Prescribing Information for MIEBO (perfluorohexyloctane ophthalmic solution).
Comments